Trump’s newest CDC pick comes with a glowing review from a familiar boss, and a not-so-subtle warning about the building she would inherit.
What You Should Know
Former Surgeon General Jerome Adams praised Dr. Erica Schwartz, President Trump’s nominee to lead the CDC, as highly qualified. Adams also said the CDC’s recent leadership turmoil and RFK’s vaccine skepticism could shape Schwartz’s confirmation and her ability to follow evidence.
Schwartz is not a cable-news celebrity, and that may be the point. She worked in the first Trumpand administration and knows the agency’s internal rhythms. Now, she is walking back into a political environment where vaccine policy is treated like a campaign issue, not a lab question.
A CDC Nominee With a Resume and a Target
On April 19th, 2026, Adams went on CBS News’ “Face the Nation” and called Schwartz a “home run pick” to lead the Centers for Disease Control and Prevention. He knows her well. He served as Trump’s Surgeon General during the first term, and Schwartz served as his deputy Surgeon General, according to CBS News.

Adams also laid out her credentials in unusually specific terms for Sunday TV: Brown University medical training, a law degree from the University of Maryland, and 24 years in the U.S. Public Health Service Commissioned Corps. CBS News reported she is currently the Coast Guard’s director of health, safety, and work-life, overseeing health operations across dozens of facilities.
Kennedy, Vaccines, and the Agency’s Recent Turnover
The compliment came with a trapdoor. Adams said Schwartz’s skill set does not erase the power dynamics above her, namely, a Health and Human Services Department led by Robert F. Kennedy Jr., whom Adams described as “vaccine-skeptical.” “Recent history tells us if she’s confirmed, she will be under real threat to follow ideology over evidence in what is a vaccine-skeptical HHS,” Adams said.
He pointed to the recent churn at the CDC as the context voters rarely see, but staffers live inside. CBS News reported that the previous CDC director, Susan Monarez, was ousted weeks after confirmation, after clashes with Kennedy, and that multiple top CDC officials resigned, citing disagreements over vaccine policy and what they called the “weaponization of public health.”
The Senate Vote Is the Real Stress Test
Adams also previewed the most politically expensive part of Schwartz’s path: the Senate hearing. He predicted she would be “pitted against RFK on vaccines” during confirmation, while noting reports that the White House has urged Kennedy to stop attacking vaccines ahead of midterm elections, according to CBS News.
The consequence is greater than the sum of one nominee’s resume. The CDC’s authority depends on persuading the public that its guidance is rooted in data, and the Senate’s job, as the chamber describes its role in nominations, is to test whether an appointee can do the job under pressure. Schwartz’s hearing will show whether the administration wants a CDC director who can contradict HHS when the evidence demands it.